Urodynamic parameters after solifenacin treatment in men with overactive bladder symptoms and detrusor underactivity

Neurourology and Urodynamics

Volumn 28, Issue 1, 2009, Pages 52-57

  Ronchi, Piero ^a   Gravina, Giovanni Luca ^a   Galatioto, Giuseppe Paradiso ^a   Costa, Alessia Mariagrazia ^a   Martella, Oreste ^a   Vicentini, Carlo ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Acute urinary retention; Detrusor underactivity; LUTS; Solifenacin; Voiding disorders

Indexed keywords

SOLIFENACIN; MUSCARINIC RECEPTOR BLOCKING AGENT; QUINUCLIDIN 3' YL 1 PHENYL 1,2,3,4 TETRAHYDROISOQUINOLINE 2 CARBOXYLATE MONOSUCCINATE; QUINUCLIDIN-3'-YL-1-PHENYL-1,2,3,4-TETRAHYDROISOQUINOLINE-2-CARBOXYLATE MONOSUCCINATE; QUINUCLIDINE DERIVATIVE; TETRAHYDROISOQUINOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLADDER CONTRACTION; BLADDER NECK STENOSIS; BLURRED VISION; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CYSTOMETRY; DETRUSOR DYSSYNERGIA; DRUG EFFICACY; DRUG RESPONSE; DRUG WITHDRAWAL; HUMAN; INCIDENCE; LOWER URINARY TRACT SYMPTOM; MALE; MICTURITION; MICTURITION DISORDER; OVERACTIVE BLADDER; PATIENT COMPLIANCE; PRETEST POSTTEST DESIGN; REGRESSION ANALYSIS; SELF CONCEPT; URINE RETENTION; URINE VOLUME; URODYNAMICS; XEROSTOMIA; BLADDER; DRUG EFFECT; MIDDLE AGED; MUSCLE CONTRACTION; PATHOPHYSIOLOGY; PERCEPTION; PROSPECTIVE STUDY; QUALITY OF LIFE; TIME; TREATMENT OUTCOME;

AGED; HUMANS; MALE; MIDDLE AGED; MUSCARINIC ANTAGONISTS; MUSCLE CONTRACTION; PERCEPTION; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUINUCLIDINES; TETRAHYDROISOQUINOLINES; TIME FACTORS; TREATMENT OUTCOME; URINARY BLADDER; URINARY BLADDER, OVERACTIVE; URODYNAMICS;

EID: 59449104548     PISSN: 07332467     EISSN: 15206777     Source Type: Journal    
DOI: 10.1002/nau.20586     Document Type: Article

References (16)

1. Abrams P, Cardozo L, Fall M, et al. The standardization of therminology in lower urinary tract function: Report from the standardization sub-committee of the International Continence Society. Urology 2003;61: 37-44.
2. Abrams P, Shah PJR, Feneley RCL. Voiding disorders in the young male adult. Urology 1981;18:107-13.
3. Thomas AW, Cannon A, Bartlett E, et al. The natural history of lower urinary tract dysfunction in men: Minimum 10-year urodynamic follow-up of untreated detrusor underactivity. BJU Int 2005;96:1295-300.
4. Anderson KE, Yoshida M. Antimuscarinics and the overactive detrusor-Which is the mechanism of action? Eur Urol 2003;43:1-5.
5. Maniscalco M, Singh-Franco D, Wolowich RW, et al. Solifenacin succinate foer the treatment of symptoms of overactive bladder. Clin Ther 2006;28: 1247-72.
6. Abrams P, Kaplan S, De Koning Gans HJ, et al. Safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction. J Urol 2006;175:999-1004.
7. Abrams P. Bladder outlet obstruction index, bladder contractility index and bladder voiding efficiency: Three simple indices to define bladder voiding function. BJU Int 1999;84:14.
8. Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function: Report from the standardisation subcommittee of the International Continence Society. Neurourol Urodyn 2002; 21:167-78.
9. Abrams P. In support of pressure-flow studies for evaluating men with lower urinary tract symptoms. Urology 1994;44:153-9.
10. Novara G, Galfano A, Gardi M, et al. Critical review of guidelines for BPH and treatment strategy. Eur Urol Suppl 2006;5:418-29.
11. Novara G, Glafano A, Ficarra V, et al. Anticholinergic drugs in patients with bladder outlet obstruction and lower urinary tract symptoms: A systematic review. Eur Urol 2006;50:675-83.
12. Anderson KE, Yoshida M. Antimuscarinics and the overactive detrusor-Which is the main mechanism of action? Eur Urol 2003;43: 1-5.
13. Anderson KE. Antimuscarinics for treatment of overactive bladder. Lancet Neurol 2003;3:46-53.
14. Schaefer W. Re: Safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction. J Urol 2006;176: 2311-2.
15. Nordling J. The aging bladder: A significant but underestimated role in the development of lower urinary tract symptoms. Exp Gerontol 2002;37: 991-9.
16. Griffiths DJ, Constantinou CE, van Mastrigt R. Urinary bladder function and its control in healthy females. Am J Physiol 1986;251:R225-30.